Locations
San Francisco, CA, USA · Kearny, NJ, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2019
Faeth Therapeutics is pioneering a new treatment paradigm for cancer by utilizing metabolism and precision nutrition. The company employs a systematic approach that combines computational biology and AI to understand the metabolic processes fueling cancer cell growth. Unlike traditional therapies that target single pathways, Faeth's multi-nodal treatment approach aims to fully inhibit cancer cell growth by improving and expanding available drug targets. With a data-driven and evidence-based methodology, Faeth is currently conducting multiple clinical trials, leveraging a discovery platform that matches tumor genotypes with tailored treatment regimens and precision diets to enhance patient outcomes. The company is positioned at the forefront of cancer treatment innovation, backed by leading investors and a team of world-class scientists.
Something looks off?